Skip to main content

AdvanSix Inc

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

ASIX$15.40-1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of AdvanSix Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of AdvanSix Inc. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations, of comprehensive income, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue Recognition – Transfer of Control

As described in Notes 2 and 3 to the consolidated financial statements, the Company recorded $1,518 million in sales for the year ended December 31, 2024 of which a significant portion has transfer of control to the customer through commercially acceptable shipping or destination point terms. Sales of the Company’s products to customers are made under a purchase order, and in certain cases in accordance with the terms of a master services agreement. Management considers the performance obligation satisfied at the point in time when control of the product is transferred to the customer, which is indicated by shipment of the product and transfer of title and risk of loss to the customer. Transfer of control to the customer occurs through various modes of shipment, including trucks, railcars, and vessels, and follows a variety of commercially acceptable shipping or destination point terms pursuant to the arrangement with the customer.

The principal considerations for our determination that performing procedures relating to revenue recognition – transfer of control is a critical audit matter are a high degree of auditor subjectivity and effort in performing procedures and evaluating audit evidence relating to the determination of the point in time when control of the product was transferred to the customer and thus revenue was recognized.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process, including controls over the point in time when control of the product was transferred to the customer. These procedures also included, among others (i) testing sales transactions based on comparing data points such as invoice amount, invoice date, shipment date, price, and quantity; (ii) for a sample of data points, testing the completeness and accuracy of the data points used by management by obtaining and inspecting source documents, such as master sales agreements, purchase orders, invoices, proof of shipment and subsequent cash receipts; and (iii) for a sample of sales transactions before and subsequent to December 31, 2024, testing when control of the product was transferred to the customer by obtaining and inspecting source documents, such as purchase orders and proof of shipment.

/s/PricewaterhouseCoopers LLP

Florham Park, NJ

February 21, 2025

We have served as the Company’s auditor since 2015.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except share and per share amounts)

Years Ended December 31,
202420232022
Sales$1,517,557$1,533,599$1,945,640
Costs, expenses and other:
Costs of goods sold1,364,6211,368,5111,631,161
Selling, general and administrative expenses94,02395,53887,748
Interest expense, net11,3117,4852,781
Other non-operating (income) expense, net2,027(7,158)(1,841)
Total costs, expenses and other1,471,9821,464,3761,719,849
Income before taxes45,57569,223225,791
Income tax expense1,42614,60053,905
Net income$44,149$54,623$171,886
Earnings per common share
Basic$1.65$2.00$6.15
Diluted$1.62$1.95$5.92
Weighted average common shares outstanding
Basic26,828,33827,302,25427,969,436
Diluted27,255,21328,007,63029,031,107

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Years Ended December 31,
202420232022
Net income$44,149$54,623$171,886
Foreign exchange translation adjustment(109)6314
Cash-flow hedges—(150)688
Pension obligation adjustments10,2231401,640
Other comprehensive income, net of tax10,114532,342
Comprehensive income$54,263$54,676$174,228

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except share and per share amounts)

December 31,
20242023
ASSETS
Current assets:
Cash and cash equivalents$19,564$29,768
Accounts and other receivables – net145,673165,393
Inventories – net212,386211,831
Taxes receivable5031,434
Other current assets8,99011,378
Total current assets387,116419,804
Property, plant and equipment – net917,858852,642
Operating lease right-of-use assets153,43895,805
Goodwill56,19256,192
Intangible assets43,14446,193
Other assets37,17225,384
Total assets$1,594,920$1,496,020
LIABILITIES
Current liabilities:
Accounts payable$228,761$259,068
Accrued liabilities47,26444,086
Operating lease liabilities – short-term42,49332,053
Income taxes payable1,0478,033
Deferred income and customer advances37,53815,678
Total current liabilities357,103358,918
Deferred income taxes145,299151,059
Operating lease liabilities – long-term111,40063,961
Line of credit – long-term195,000170,000
Postretirement benefit obligations—3,660
Other liabilities11,4689,185
Total liabilities820,270756,783
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS' EQUITY
Common stock, par value $0.01; 200,000,000 shares authorized; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024; 32,598,946 shares issued and 26,750,471 outstanding at December 31, 2023330326
Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2024 and 2023——
Treasury stock at par (6,252,129 shares at December 31, 2024; 5,848,475 shares at December 31, 2023)(63)(58)
Additional paid-in capital136,872138,046
Retained earnings631,541605,067
Accumulated other comprehensive income (loss)5,970(4,144)
Total stockholders' equity774,650739,237
Total liabilities and stockholders' equity$1,594,920$1,496,020

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years Ended December 31,
202420232022
Cash flows from operating activities:
Net income$44,149$54,623$171,886
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization76,17673,01069,353
Loss on disposal of assets7731,2811,521
Deferred income taxes(8,991)(9,347)16,228
Stock-based compensation7,8548,31310,279
Amortization of deferred financing fees618618618
Operational asset adjustments1,200(4,472)—
Changes in assets and liabilities, net of business acquisitions:
Accounts and other receivables18,41121,48917,842
Inventories(555)3,286(57,043)
Taxes receivable9318,337(8,824)
Accounts payable(30,610)(20,756)55,863
Income taxes payable(6,986)8,003(9,693)
Accrued liabilities2,426(5,569)(3,122)
Deferred income and customer advances21,860(18,752)31,681
Other assets and liabilities8,157(2,514)(22,988)
Net cash provided by operating activities135,413117,550273,601
Cash flows from investing activities:
Expenditures for property, plant and equipment(133,722)(107,377)(89,449)
Acquisition of businesses——(97,456)
Other investing activities(9,180)(3,520)(2,368)
Net cash used for investing activities(142,902)(110,897)(189,273)
Cash flows from financing activities:
Borrowings from line of credit406,000437,000434,500
Payments of line of credit(381,000)(382,000)(454,500)
Principal payments of finance leases(1,011)(938)(926)
Dividend payments(17,135)(16,657)(15,073)
Purchase of treasury stock(10,428)(46,151)(33,748)
Issuance of common stock8598761,304
Net cash used for financing activities(2,715)(7,870)(68,443)
Net change in cash and cash equivalents(10,204)(1,217)15,885
Cash and cash equivalents at beginning of period29,76830,98515,100
Cash and cash equivalents at the end of period$19,564$29,768$30,985
Supplemental non-cash investing activities:
Capital expenditures included in accounts payable$23,645$22,660$14,879
Supplemental cash activities:
Cash paid for interest$10,828$7,086$2,239
Cash paid for income taxes$18,953$7,790$56,170

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Common Stock · AdditionalPaid-InCapital · Retained Earnings · Treasury Stock · Accumulated OtherComprehensiveIncome (Loss) · Total Equity
SharesAmount
Balance at December 31, 202131,755,430$318$195,931$411,516$(36)$(6,539)$601,190
Net Income———171,886——171,886
Comprehensive income
Foreign exchange translation adjustments—————1414
Cash-flow hedges—————688688
Pension obligation adjustments—————1,6401,640
Other comprehensive income (loss), net of tax—————2,3422,342
Issuance of common stock222,16321,302———1,304
Acquisition of treasury shares ( 915,597 shares)——(33,739)—(9)—(33,748)
Stock-based compensation——10,279———10,279
Dividends——812(15,885)——(15,073)
Balance at December 31, 202231,977,593320174,585567,517(45)(4,197)738,180
Net Income———54,623——54,623
Comprehensive income
Foreign exchange translation adjustments—————6363
Cash-flow hedges—————(150)(150)
Pension obligation adjustments—————140140
Other comprehensive income (loss), net of tax—————5353
Issuance of common stock621,3536870———876
Acquisition of treasury shares (1,317,402 shares)——(46,138)—(13)—(46,151)
Stock-based compensation——8,313———8,313
Dividends——416(17,073)——(16,657)
Balance at December 31, 202332,598,946326138,046605,067(58)(4,144)739,237
Net Income———44,149——44,149
Comprehensive income
Foreign exchange translation adjustments—————(109)(109)
Pension obligation adjustments—————10,22310,223
Other comprehensive income (loss), net of tax—————10,11410,114
Issuance of common stock390,2194855———859
Acquisition of treasury shares (403,654 shares)——(10,423)—(5)—(10,428)
Stock-based compensation——7,854———7,854
Dividends——540(17,675)——(17,135)
Balance at December 31, 202432,989,165$330$136,872$631,541$(63)$5,970$774,650

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts or unless otherwise noted)

Note 1. Organization, Operations and Basis of Presentation

Description of Business

AdvanSix Inc. (“AdvanSix,” the “Company,” “we,” "us" or “our”) is a diversified chemistry company playing a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people’s lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Our reliable and sustainable supply of quality products emerges from the integrated value chain of ourfive U.S.-based manufacturing facilities. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients and chemical intermediates, guided by our core values of Safety, Integrity, Accountability and Respect.

We evaluated segment reporting in accordance with Accounting Standards Codification Topic (“ASC”) 280. We concluded that AdvanSix is a single operating segment and a single reportable segment based on the operating results available which are evaluated regularly by the chief operating decision maker (“CODM”) to make decisions about resource allocation and performance assessment on a consolidated basis. Our larger manufacturing sites are vertically integrated and leverage cross-plant resources, including centralized supply chain and procurement functions. This production process uses one key raw material, cumene, as the input to products produced for sale through the sales channels and end markets the Company serves. Production rates and output volumes are managed across locations to align with the overall Company operating plan.

AdvanSix operates through five U.S.-based manufacturing sites located in Frankford, Pennsylvania, Chesterfield, Virginia, Hopewell, Virginia, Portsmouth, Virginia and Bucks, Alabama. The Company's headquarters is located in Parsippany, New Jersey.

Corporate History

On October 1, 2016, Honeywell International Inc. (“Honeywell”) completed the separation of AdvanSix. The separation was completed by Honeywell distributing (the "Distribution") all of the then outstanding shares of common stock of AdvanSix on October 1, 2016 (the “Distribution Date”) through a dividend in kind of AdvanSix common stock, par value $0.01 per share, to holders of Honeywell common stock as of the close of business on the record date of September 16, 2016 who held their shares through the Distribution Date.

Basis of Presentation

Unless the context otherwise requires, references in these Notes to the Consolidated Financial Statements to “we,” “us,” “our,” “AdvanSix” and the “Company” refer to AdvanSix Inc. and its consolidated subsidiaries after giving effect to the Spin-Off. All intercompany transactions have been eliminated.

Note 2. Summary of Significant Accounting Policies

Accounting Principles – The financial statements and accompanying Notes are prepared in accordance with accounting principles generally accepted in the United States of America. The following is a description of AdvanSix’s significant accounting policies.

Principles of Consolidation – The Consolidated Financial Statements include the accounts of AdvanSix and all of its subsidiaries in which a controlling financial interest is maintained. Our consolidation policy requires equity investments that we exercise significant influence over but do not control the investee and are not the primary beneficiary of the investee’s activities to be accounted for using the equity method. Investments through which we are not able to exercise significant influence over the investee and which we do not have readily determinable fair values are accounted for under the cost method. All intercompany transactions and balances are eliminated in consolidation.

Cash and Cash Equivalents – Cash and cash equivalents include cash on hand and on deposit and highly liquid, temporary cash investments with an original maturity to the Company of three months or less. We reduce cash and extinguish liabilities when the creditor receives our payment and we are relieved of our obligation for the liability when checks clear the Company’s bank account.

Liabilities to creditors to whom we have issued checks that remain outstanding aggregated $7.3 million at December 31, 2024 and are included in Cash and cash equivalents and Accounts payable in the Consolidated Balance Sheets.

Fair Value Measurement – ASC 820, Fair Value Measurement defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Financial Accounting Standards Board's ("FASB") guidance classifies the inputs used to measure fair value into the following hierarchy:

Level 1Unadjusted quoted prices in active markets for identical assets or liabilities
Level 2Unadjusted quoted prices in active markets for similar assets or liabilities, or
Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability
Level 3Unobservable inputs for the asset or liability

Financial and non-financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The pension plan assets are invested in collective investment trust funds. These investments are measured at fair value using the net asset value per share practical expedient. Investments valued using the net asset value method (NAV) (or its equivalent) practical expedient are excluded from the fair value hierarchy disclosure.

The Company’s Consolidated Balance Sheets include Cash and cash equivalents, Accounts receivable and Accounts payable all of which are recorded at amounts which approximate fair value.

The Company also has assets that are required to be recorded at fair value on a non-recurring basis. These assets are evaluated when certain triggering events occur (including a decrease in estimated future cash flows) that indicate the asset should be evaluated for impairment. Goodwill and indefinite lived intangible assets must be evaluated at least annually.

Derivative Financial Instruments – We minimize our risks from interest and foreign currency exchange rate fluctuations through our normal operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. Derivative financial instruments are used to manage risk and are not used for trading or other speculative purposes. Derivative financial instruments that qualify for hedge accounting must be designated and effective as a hedge of the identified risk exposure at the inception of the contract. Accordingly, changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception of the hedge and over the life of the hedge contract.

All derivatives are recorded on the balance sheet as assets or liabilities and measured at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair values of both the derivatives and the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the changes in fair value of the derivatives are recorded in Accumulated other comprehensive income (loss) and subsequently recognized in earnings when the hedged items impact earnings. Cash flows of such derivative financial instruments are classified consistent with the underlying hedged item. For derivative instruments that are designated and qualify as a net investment hedge, the derivative’s gain or loss is reported as a component of Other comprehensive income (loss) and recorded in Accumulated other comprehensive income (loss). The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.

Commodity Price Risk Management – The Company's exposure to market risk for commodity prices can result in changes in our cost of production. We primarily mitigate our exposure to commodity price risk by using long-term, formula-based price contracts with our suppliers and formula-based price agreements with customers. Our customer agreements provide for price adjustments based on relevant market indices and raw material prices, and generally they do not include take-or-pay terms. Instead, each customer agreement, the majority of which have a term of at least one year, is typically determined by monthly or quarterly volume estimates. We may also enter into forward commodity contracts with third parties designated as hedges of anticipated purchases of several commodities. Forward commodity contracts are marked-to-market, with the resulting gains and losses recognized in earnings, in the same category as the items being hedged, when the hedged transaction is recognized. At December 31, 2024 and 2023, we hadno contracts with notional amounts related to forward commodity agreements.

Credit and Market Risk Management– The Company manages its exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties, and procedures to monitor concentrations of credit risk. The Company continually monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The terms and conditions of credit sales are designed to mitigate or eliminate concentrations of credit risk with any single customer. The Company did not have any customers with significant concentrations of trade accounts receivable – net at December 31, 2024 and 2023. Allowance for doubtful accounts is calculated based upon the Company's estimate of expected credit losses over the life of exposure based upon both historical information as well as future expected losses.

Inventories – Substantially all of the Company's inventories are valued at the lower of cost or market using the last-in, first-out (“LIFO”) method. The Company includes spare and other parts in inventory which are used in support of production or production facilities operations and are valued based on weighted average cost.

Inventories valued at LIFO amounted to $196.5 million and $195.6 million at December 31, 2024 and 2023, respectively. Had such LIFO inventories been valued at current costs, their carrying values would have been approximately $64.1 million and $95.2 million higher at December 31, 2024 and 2023. Inventories valued at FIFO amounted to $15.9 million and $16.2 million at December 31, 2024 and 2023, respectively.

Property, Plant, Equipment – Property, plant, equipment asset values are recorded at cost, including any asset retirement obligations, less accumulated depreciation. For financial reporting, the straight-line method of depreciation is used over the estimated useful lives of 10 to 40 years for buildings and improvements and 3 to 35 years for machinery and equipment. Our machinery and equipment includes (1) assets used in short production cycles or subject to high corrosion, such as instrumentation, controls and insulation systems with useful lives of 3 to 30 years, (2) standard plant assets, such as boilers and railcars, with useful lives ranging from 3 to 30 years and (3) major process equipment that can be used for long durations with effective preventative maintenance and repair, such as cooling towers, compressors, tanks and turbines with useful lives ranging from 3 to 35 years. Recognition of the fair value of obligations associated with the retirement of tangible long-lived assets is required when there is a legal obligation to incur such costs. Upon initial recognition of a liability, the cost is capitalized as part of the related long-lived asset and depreciated over the corresponding asset’s useful life.

Repairs and maintenance, including planned major maintenance, are expensed as incurred. Costs which materially add to the value of the asset or prolong its useful life are capitalized and the replaced assets are retired.

Long-Lived Assets – The Company evaluates the recoverability of the carrying amount of long-lived assets (including property, plant and equipment and intangible assets with determinable lives) whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. The Company evaluates events or changes in circumstances based on several factors including operating results, business plans and forecasts, general and industry trends, and economic projections and anticipated cash flows. An impairment is assessed when the undiscounted expected future cash flows derived from an asset are less than its carrying amount. Impairment losses are measured as the amount by which the carrying value of an asset exceeds its fair value and are recognized in the Consolidated Statements of Operations. The Company also evaluates the estimated useful lives of long-lived assets if circumstances warrant and revises such estimates based on current events.

Goodwill – The Company had goodwill of $56.2 million at December 31, 2024 and 2023. Goodwill is subject to impairment testing annually on the last day of our October close, or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. Management first assesses qualitative factors as described in ASC 350 to determine whether it is necessary to perform the quantitative goodwill impairment test. Potential impairment is identified by comparing the fair value of a reporting unit to the carrying value, including goodwill. The Company completed its annual goodwill impairment test as of October 26, 2024 and, based on the results of the Company's assessment of qualitative factors, it was determined that it was not necessary to perform the quantitative goodwill impairment test.

Finite-Lived Intangible Assets – Other intangible assets with determinable lives consist of customer relationships, trademarks, patents and other intangibles and are amortized over their estimated useful lives, ranging from 5 to 20 years.

Revenue Recognition – The Company recognizes revenue upon the transfer of control of goods or services to customers at amounts that reflect the consideration expected to be received. AdvanSix primarily recognizes revenues when title and control of the product transfers from the Company to the customer. Outbound shipping costs incurred by the Company are not included in revenues but are reflected as freight expense in Costs of goods sold in the Consolidated Statements of Operations.

Sales of our products to customers are made under a purchase order, and in certain cases in accordance with the terms of a master services agreement. These agreements typically contain formula-based pass-through pricing tied to key feedstock materials and volume ranges, but often do not specify the goods, including the quantities thereof, to be transferred. Certain master services agreements (including with respect to our largest customer) may contain minimum purchase volumes which can be satisfied by the customer on a periodic basis by choosing from various products offered by the Company. In these cases, a performance obligation is created when a customer submits a purchase order for a specific product at a specified price, typically providing for delivery within the next 60 days. Management considers the performance obligation with respect to such purchase order satisfied at the point in time when control of the product is transferred to the customer, which is indicated by shipment of the product and transfer of title and risk of loss to the customer. Transfer of control to the customer occurs through various modes of shipment, including trucks, railcars, and vessels, and follows a variety of commercially acceptable shipping or destination point terms pursuant to the arrangement with the customer. Variable consideration is estimated for future volume rebates and early pay discounts on certain products and product returns. The Company records variable consideration as an adjustment to the sale transaction price. Since variable consideration is generally settled within one year, the time value of money is not significant.

The Company applies the practical expedient in Topic 606 and does not include disclosures regarding remaining performance obligations that have original expected durations of one year or less, or amounts for variable consideration allocated to wholly-unsatisfied performance obligations or wholly-unsatisfied distinct goods that form part of a single performance obligation, if any.

The Company also utilizes the practical expedient in Topic 606 and does not include an adjustment for the effects of a significant financing component given the expected period duration of one year or less.

Environmental – The Company accrues costs related to environmental matters when it is probable that we have incurred a liability related to a contaminated site and the amount can be reasonably estimated.

Deferred Income and Customer Advances– AdvanSix typically has an annual pre-buy program for ammonium sulfate that is classified as deferred income and customer advances in the Consolidated Balance Sheets. Customers pay cash in advance to reserve capacity for ammonium sulfate to guarantee product availability during peak planting season. The Company recognizes a customer advance when cash is received for the advanced buy. Revenue is then recognized and the customer advance is relieved upon title transfer of ammonium sulfate.

Trade Receivables and Allowance for Credit Losses – Trade accounts receivables are recorded at the invoiced amount as a result of transactions with customers. AdvanSix maintains allowances for credit losses for estimated losses based on a customer’s inability to make required payments. AdvanSix estimates anticipated losses from doubtful accounts based on days past due, as measured from the contractual due date and historical collection history and incorporates changes in economic conditions that may not be reflected in historical trends such as customers in bankruptcy, liquidation or reorganization. Receivables are written-off against the allowance for credit losses when they are determined uncollectible. Such determination includes analysis and consideration of the particular conditions of the account, including time intervals since last collection, customer performance against agreed upon payment plans, success of outside collection agencies activity, solvency of customer and any bankruptcy proceedings.

Research and Development – AdvanSix conducts research and development (“R&D”) activities, which consist primarily of the development of new products and product applications consisting primarily of labor costs and depreciation and maintenance costs. R&D costs are charged to expense as incurred. Such costs are included in costs of goods sold and were $8.8 million, $9.8 million, and $12.5 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Debt Issuance Costs – Debt issuance costs are capitalized as a component of Other assets and are amortized through interest expense over the related term.

Stock-Based Compensation Plans – The principal awards issued under our stock-based compensation plans, which are described in "Note 14. Stock-Based Compensation Plans" to the Consolidated Financial Statements included in Item 8 of this Form 10-K, are non-qualified stock options, performance stock units and restricted stock units. The cost for such awards is measured at the grant date based on the fair value of the award. The value of the portion of the award that is ultimately expected to vest, including the impact of the Company's anticipated performance against certain metrics for performance stock units, is recognized as expense over the requisite service periods (generally the vesting period of the equity award) and is included in selling, general and administrative expenses. Estimates of future performance are utilized to determine the underlying expense for shares expected to vest. Forfeitures are estimated at the time of grant to recognize expense for those awards that are expected to vest and are based on our historical forfeiture rates.

Dividend Equivalents – If a dividend is authorized by the Board for stockholders of common stock, holders of unvested RSUs and unvested PSUs will have their accounts credited with dividend equivalents in the form and in an amount equal to the dividend that the holder would have received had the shares underlying the RSUs and PSUs been distributed at the time that such dividend was paid. Dividend equivalents are subject to the same vesting, forfeiture, performance and payment restrictions as the respective equity award for which it is attributable. Since the dividend equivalents are forfeitable, there is no impact on the basic earnings per share calculation.

Pension Benefits – We have a defined benefit plan covering certain employees primarily in the U.S. The benefits are accrued over the employees’ service periods. We use actuarial methods and assumptions in the valuation of defined benefit obligations and the determination of net periodic pension income or expense. Differences between actual and expected results or changes in the value of defined benefit obligations and fair value of plan assets, if any, are not recognized in earnings as they occur but rather systematically over subsequent periods when net actuarial gains or losses are in excess of 10% of the greater of the fair value of plan assets or the plan’s projected benefit obligation.

Foreign Currency Translation – Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates. Sales, costs and expenses are translated at the average exchange rates in effect during the year. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss) in our Consolidated Balance Sheets.

Income Taxes – We account for income taxes pursuant to the asset and liability method which requires us to recognize current tax liabilities or receivables for the amount of taxes we estimate are payable or refundable for the current year and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible.

We adopted the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s consolidated financial statements. ASC 740 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.

The benefit of tax positions taken or expected to be taken in our income tax returns are recognized in the financial statements if such positions are more likely than not of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carryover or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740. Interest costs and related penalties related to unrecognized tax benefits are required to be calculated, if applicable. Our policy is to classify tax related interest and penalties, if any, as a component of income tax expense. No interest or penalties related to unrecognized income tax benefits were recorded during the years ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, no liability for unrecognized tax benefits was required to be reported. We do not expect any significant changes in our unrecognized tax benefits in the next year.

Leases – The Company enters into agreements to lease transportation equipment, storage facilities, office space, dock access and other equipment. Operating leases have initial terms of up to 20 years with some containing renewal options subject to customary conditions.

An arrangement is considered to be a lease if the agreement conveys the right to control the use of the identified asset in exchange for consideration.

Operating leases, which are reported as Operating lease right-of-use assets, and Operating lease liabilities – short-term and Operating lease liabilities – long-term are included in our Consolidated Balance Sheets. Finance leases are included as a component of Property, plant and equipment – net, Accounts payable and Other liabilities in our Consolidated Balance Sheets.

Upon adoption of ASU 2016-02, Leases (Topic 842), the Company elected the following practical expedients available in Topic 842:

the package of three expedients which allows the Company to not re-assess (i) whether any expired or existing contracts are, or contain, leases, (ii) lease classification for any expired or existing leases, and (iii) initial direct costs for any expired or existing leases;

the short-term lease practical expedient, which allows the Company to exclude leases with an initial term of 12 months or less ("short-term leases") from recognition in the Consolidated Balance Sheets;

the bifurcation of lease and non-lease components practical expedients, which did not require the Company to bifurcate lease and non-lease components for real estate leases; and

the land easements practical expedient, which allows the Company to carry forward the accounting treatment for land easements on existing agreements.

Earnings Per Share – Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.

Treasury Stock– The Company has elected to account for treasury stock purchased under the constructive retirement method. For shares repurchased in excess of par, the Company will allocate the excess value to additional paid-in capital.

Use of Estimates – The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the Consolidated Financial Statements and related disclosures in the accompanying Notes. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of changes are reflected in the Consolidated Financial Statements in the period they are determined to be necessary.

Reclassifications – Certain prior period amounts have been reclassified for consistency with the current period presentation.

Recent Accounting Pronouncements – The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position or results of operations.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this ASU require disclosure, in the notes to the financial statements, of specified information about certain costs and expenses. The amendments require that at each interim and annual reporting period and entity will: (1) disclose the amounts of (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization and depreciation, depletion, and amortization recognized as part of oil-and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement within continuing operations that contains any of the expense categories listed in (a)-(e), (2) include certain amounts that are already required to be disclosed under current generally accepted accounting principles (GAAP) in the same disclosure as other disaggregation requirements (3) disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and (4) disclose the total amount of selling expense and, in annual reporting periods, an entity's definition of selling expense. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is evaluating the pronouncement and does not expect adoption to have a material impact on the Company's consolidated financial position or results of operations.

On December 13, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this ASU require that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The amendments also require that the Company disclose the following (net of refunds received): (1) the amount of income taxes paid disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. Additionally, the amendments in this update eliminate the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or to make a statement that an estimate of the range cannot be made, and remove the requirement to disclose the cumulative amount of each type of temporary difference when a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes related to subsidiaries and corporate joint ventures. The guidance is effective for public business entities for annual periods beginning after December 15, 2024. Early adoption of the amendments in this update is permitted for annual financial statements that have not yet been issued. The Company is evaluating the pronouncement and does not expect adoption to have a material impact on the Company's consolidated financial position or results of operations.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). The amendments in this ASU require incremental disclosures about the Company's reportable segments, but do not change the definition of a segment or the guidance for determining reportable segments. The incremental disclosures should include (1) significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, (2) an amount for other segment items by reportable segment and a description of its composition, (3) profit or loss and assets currently required by Topic 280 in interim periods, (4) clarification if the CODM uses more than one measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources and (5) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for public entities with fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Additionally, public entities should apply the amendments retrospectively to all prior periods presented in the financial statements, unless impractical. The Company adopted ASU 2023-07 effective December 31, 2024, which did not have any impact on the Company's consolidated financial position or results of operations upon adoption.

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments in this ASU require that a buyer in a supplier finance program disclose sufficient quantitative and qualitative information about its supplier finance programs to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period and potential magnitude. On a retrospective basis, for each annual reporting period, an entity should disclose the key terms of the program, including a description of the payment terms, assets pledged as security or other forms of guarantees, the confirmed amount outstanding that remains unpaid, a description of where the obligations are presented in the balance sheet and a roll-forward of those obligations confirmed as well as the amount of obligations subsequently paid. In each interim reporting period, an entity should disclose the amount of confirmed obligations outstanding. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll-forward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption of the amendments in this update is permitted. The Company adopted ASU 2022-04, effective January 1, 2023, which did not have a material impact on the Company's consolidated financial position or results of operations upon adoption.

Note 3. Revenue

AdvanSix serves around 400 customers annually, primarily in the United States, spanning a wide variety of industries worldwide. For 2024, 2023 and 2022, the Company's ten largest customers accounted for approximately 38%,39% and 39% of total sales, respectively.

We typically sell to customers under master services agreements, with primarily one-year terms, or by purchase orders. We have historically experienced low customer turnover and have an average customer relationship of approximately 20 years. Our largest customer is Shaw Industries Group Inc. ("Shaw"), a significant consumer of caprolactam and Nylon 6 resin. We sell caprolactam and Nylon 6 resin to Shaw under a long-term agreement. Sales to Shaw were 10% of our total sales for the year ended December 31, 2024,11% for the year ended December 31, 2023 and 12% for the year ended December 31, 2022.

The Company’s revenue by product line, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:

Twelve Months Ended December 31, 2024 and 2023
2024 · 2023 · 2022
Nylon$348,50123%$356,63223%$485,24125%
Caprolactam276,30318%298,37520%319,86316%
Plant Nutrients*458,15230%477,92931%657,98434%
Chemical Intermediates*434,60129%400,66326%482,55225%
$1,517,557100%$1,533,599100%$1,945,640100%
  • The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

The Company’s revenues by geographic area, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:

Twelve Months Ended December 31, 2024 and 2023
2024 · 2023 · 2022
United States$1,304,97186%$1,250,09482%$1,622,53783%
International212,58614%283,50518%323,10317%
Total$1,517,557100%$1,533,599100%$1,945,640100%

Deferred Income and Customer Advances

The Company defers revenues when cash payments are received in advance of our performance. Customer advances relate primarily to sales from the ammonium sulfate business. Below is a roll-forward of Deferred income and customer advances for the twelve months ended December 31, 2024:

Deferred Income and Customer Advances2024
Opening balance January 1, 2024$15,678
Additional cash advances37,954
Less amounts recognized in revenues(16,094)
Ending balance December 31, 2024$37,538

The Company expects to recognize as revenue the December 31, 2024 ending balance of Deferred income and customer advances within one year or less.

Note 4. Income Taxes

Years Ended December 31,
202420232022
Income before taxes
U.S.$45,497$69,055$225,640
Non-U.S.78168151
$45,575$69,223$225,791

Income taxes

Income tax expense (benefit) consists of:

Years Ended December 31,
202420232022
Current Provision (benefit):
Federal$7,525$20,707$31,165
State2,8653,1596,463
Non-U.S.234748
Total current provision (benefit)$10,413$23,913$37,676
Deferred Provision (benefit):
Federal$(8,192)$(8,886)$13,874
State(795)(427)2,355
Non-U.S.———
Total deferred provision (benefit)(8,987)(9,313)16,229
Total income tax expense (benefit)$1,426$14,600$53,905

The U.S. federal statutory income tax rate is reconciled to the effective income tax rate as follows:

Years Ended December 31,
202420232022
U.S. federal statutory income tax rate21.0%21.0%21.0%
U.S. state income taxes3.4%2.9%3.1%
U.S. state income tax rate change0.2%0.2%—%
Excess tax benefits of equity compensation—%(1.5)%—%
Executive compensation limitations1.8%1.0%0.7%
Research and other tax credits(2.7)%(1.3)%(0.3)%
Energy credits(21.4)%—%—%
Prior year return to provision adjustments2.1%(0.4)%—%
Foreign derived intangible income deduction(1.3)%(0.9)%(0.7)%
Other, net—%0.1%0.1%
Effective income tax rate3.1%21.1%23.9%

Generally, the Company's effective income tax rate is increased relative to the U.S. statutory rate of 21% due to state taxes and executive compensation limitations, which are generally offset by research tax credits, excess tax benefits of equity compensation and the foreign derived intangible income deduction.

The Company's effective income tax rate for 2024 was significantly less than the U.S. Federal statutory rate of 21% due to approximately $9.7 million in income tax benefits associated with prior year refund claims, specifically related to Internal Revenue Code (IRC) Section 45Q tax credits generated in the 2018 and 2019 tax periods. IRC Section 45Q allows taxpayers to receive a tax credit for carbon capture and utilization at its facilities. For certain utilization projects, the 45Q tax credit requires approval by the Internal Revenue Service (IRS) of a life-cycle assessment ("LCA") prior to claiming the tax credits. The Company received approval for its 2018 LCA in November 2024 which enables the Company to claim credits for the 2018 and 2019 years. The Company continues to pursue credits for the periods subsequent to 2019. The 45Q tax credits for 2018 and 2019 have been recorded as a reduction in the Company's Income taxes payable account.

Additionally, in 2024 the Company recorded 2023 return to provision adjustments which resulted in a 2.1% increase in its current year effective income tax rate. These adjustments primarily relate to a reduction in the income tax benefits associated with the research tax credit and the foreign derived intangible income deduction as reported on the Company's 2023 income tax return as compared to amounts recorded in its 2023 Income tax expense.

The Company's effective income tax rate for 2023 approximated the U.S. Federal statutory rate of 21%. Increases to the effective income tax rate due primarily to state taxes and executive compensation limitations, were materially offset by research tax credits, excess tax benefits of equity compensation and the foreign-derived intangible income deduction.

The Company's effective income tax rate for 2022 was higher compared to the U.S. Federal statutory rate of 21% due primarily to state taxes and executive compensation deduction limitations partially offset by research tax credits and the foreign-derived intangible income deduction.

On August 16, 2022, the Inflation Reduction Act of 2022 (the "IRA") was signed into law. This legislation includes significant changes relating to tax, climate change, energy and health care. Among other provisions, the IRA introduces a corporate alternative minimum tax ("CAMT") on adjusted financial statement income of certain large corporations and a 1% excise tax on share repurchases. The Company is not currently subject to the CAMT which became effective for tax years beginning after December 31, 2022. The 1% excise tax is generally applicable to publicly traded corporations for the net value of certain stock that the corporation repurchases during the year and is also effective for tax years beginning after December 31, 2022. The impact of any excise tax imposed on the Company for share repurchases is generally accounted for as an equity transaction with no consequences to the Company's results of operations, and this provision of the law has an immaterial impact on the Company's financial condition. The IRA also includes significant extensions, expansions and enhancements related to climate and energy tax credits designed to encourage investment in the adoption and expansion of renewable and alternative energy sources. The Company continues to evaluate these energy credit provisions of the law in relation to our sustainability and environmental, social and governance initiatives.

The Company also continues to monitor any new tax legislation that would result in a material impact on its financial statements, in particular as a result of the new U.S. presidential administration and U.S. Congress.

The Pillar Two Global Anti-Base Erosion rules issued by the Organization for Economic Co-operation and Development ("OECD"), a global policy forum, introduced a global minimum tax of 15% which would apply to multinational groups with consolidated financial statement revenue in excess of EUR 750 million. Nearly all OECD member jurisdictions have agreed in principle to adopt these provisions and numerous jurisdictions, including jurisdictions where the Company operates, have enacted these rules effective January 1, 2024. The Company has evaluated the impact of these rules and currently believes they will not have any material impact on financial results through 2026 due to certain transitional safe harbors. We will continue to monitor and refine our assessment as further guidance is made available.

As of December 31, 2024 and 2023, there wereno unrecognized tax benefits recorded by the Company. Although there are no unrecognized income tax benefits, when applicable, the Company’s policy is to report interest expense and penalties related to unrecognized income tax benefits in the income tax provision.

The Company is subject to taxation in the United States and various states and foreign jurisdictions. The Company has been notified that a federal tax examination for periods 2018 and 2019 will commence, and tax periods 2021 through 2024 remain open under the statute of limitations and are subject to examination by the tax authorities. There are no current state or foreign tax examinations; however, tax years 2020 through 2024 generally remain open under the statute of limitations and are subject to examination by the tax authorities.

Deferred tax assets (liabilities)

The tax effects of temporary differences which give rise to future income tax benefits and expenses are as follows:

December 31,
20242023
Deferred tax assets:
Net operating loss$92$36
Accruals and reserves4,3172,943
Capitalization of research expenses7,7876,624
Inventory17,3469,394
Pension obligation—1,726
Operating lease liability36,93123,031
Equity compensation2,8993,025
Total gross deferred tax assets69,37246,779
Less: Valuation Allowance——
Total deferred tax assets$69,372$46,779
Deferred tax liabilities:
Property, plant & equipment$(163,991)$(160,071)
Intangibles(10,857)(11,156)
Operating lease asset(36,822)(22,981)
Pension obligation(421)—
Other(2,580)(3,630)
Total deferred tax liabilities(214,671)(197,838)
Net deferred taxes$(145,299)$(151,059)

The net deferred taxes are primarily related to U.S. operations. The Company hasno material state net operating losses (NOL) carryforwards and no federal or state tax credit carryforwards remaining as of December 31, 2024. We believe that the state NOL carryforward and other deferred tax assets are more likely than not to be realized and we havenot recorded a valuation allowance against the deferred tax assets.

The Company's accounting policy is to record the tax impacts of Global intangible low-taxed income as a period cost.

As of December 31, 2024 and 2023, there wereno material undistributed earnings of the Company's non-U.S. subsidiaries and, as such, we have not provided a deferred tax liability for undistributed earnings.

Note 5. Accounts and Other Receivables – Net

December 31,
20242023
Accounts receivables$141,273$155,267
Other4,98210,959
Total accounts and other receivables146,255166,226
Less – allowance for credit losses(582)(833)
Total accounts and other receivables – net$145,673$165,393

The roll-forward of allowance for credit losses are summarized in the table below:

Balance atBeginning ofYearCharged / (Credited) toCostsCharged toOtherAccounts (1)Bad Debt Write-Offs (1)Balance atEnd of Year
Year ended December 31, 2024$833$(893)$228$414$582
Year ended December 31, 202359445847(266)833
Year ended December 31, 20221,495(1,122)—221594

(1) No Impact to Statement of Operations

Note 6. Inventories

December 31,
20242023
Raw materials$99,320$159,240
Work in progress71,17554,936
Finished goods73,99461,891
Spares and other31,94830,931
276,437306,998
Reduction to LIFO cost basis(64,051)(95,167)
Total inventories$212,386$211,831

Substantially all of the Company’s inventories at December 31, 2024 and December 31, 2023 are valued at the lower of cost or market using the LIFO method. However, approximately 7% was valued at average cost using the first-in, first-out (“FIFO”) method at December 31, 2024.

The excess of replacement cost over the carrying value of total inventories subject to LIFO was $57.5 million and $65.3 million at December 31, 2024 and December 31, 2023, respectively.

Note 7. Property, Plant, Equipment – Net

December 31,
20242023
Land and improvements$11,761$11,761
Machinery and equipment1,698,8351,621,636
Buildings and improvements244,761228,379
Construction in progress95,05366,875
2,050,4101,928,651
Less – accumulated depreciation(1,132,552)(1,076,009)
Total property, plant, equipment – net$917,858$852,642

Capitalized interest was $5,666, $3,375 and $2,589 for the years ended December 31, 2024, 2023 and 2022, respectively.

Depreciation expense was $70,750, $67,528 and $64,087 for the years ended December 31, 2024, 2023 and 2022, respectively.

Note 8. Leases

We determine if an arrangement is a lease at inception. Operating leases, which are reported as Operating lease right-of-use assets ("ROU"), Operating lease liabilities – short-term, and Operating lease liabilities – long-term are included in our Consolidated Balance Sheets. Finance leases are included in Property, plant and equipment – net, Accounts payable, and Other liabilities in our Consolidated Balance Sheets.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease pre-payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease and, when it is reasonably certain that such an option will be exercised, it is included in the determination of the corresponding assets and liabilities. Short-term leases are not recognized on our Consolidated Balance Sheets. Lease expense for all operating lease payments is recognized on a straight-line basis over the lease term.

We have lease agreements with lease and non-lease components, which are generally accounted for separately. Additionally, for certain equipment leases, we apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities. The Company has entered into agreements to lease transportation equipment, storage facilities, office space, dock access and other equipment. The operating leases have initial terms of up to 20 years with some containing renewal options subject to customary conditions. The term and length of the various agreements, as well as the timing of any renewals, will impact the ROU asset calculation and related liability.

The components of lease expense were as follows:

Years Ended December 31,
202420232022
Finance lease cost:
Amortization of right-of-use asset$1,036$932$917
Interest on lease liabilities16310653
Total finance lease cost1,1991,038970
Operating lease cost43,51747,14843,668
Short-term lease cost6,6475,4155,338
Total lease cost$51,363$53,601$49,976

Supplemental cash flow information related to leases was as follows:

Years Ended December 31,
20242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$43,188$47,196
Operating cash flows from finance leases124106
Financing cash flows from finance leases1,011938
Non-cash information:
Right-of-use assets obtained in exchange for lease obligations:
Operating leases72,36114,818
Finance leases1,2181,325

Supplemental balance sheet information related to leases was as follows:

Years Ended December 31,
20242023
Operating Leases
Operating lease right-of-use assets$153,438$95,805
Operating lease liabilities – short term42,49332,053
Operating lease liabilities – long term111,40063,961
Total operating lease liabilities$153,893$96,014
Finance Leases
Property, plant and equipment – gross$4,131$3,528
Accumulated depreciation(1,771)(1,369)
Property, plant and equipment – net$2,360$2,159
Accounts payable$897$797
Other liabilities1,5491,400
Total finance lease liabilities$2,446$2,197
Weighted Average Remaining Lease Term
Operating leases7.2 years9.1 years
Finance leases3.1 years3.3 years
Weighted Average Discount Rate
Operating leases6.16%6.40%
Finance leases6.92%6.71%

Maturities of lease liabilities are as follows:

Year Ending December 31,Operating LeasesFinance Leases
2025$51,252$1,047
202640,462806
202730,566521
202824,359301
20299,97250
Thereafter41,88014
Total lease payments198,4912,739
Less imputed interest(44,598)(293)
Total$153,893$2,446

As of December 31, 2024, we haveno additional operating or finance leases that have not yet commenced.

Note 9. Long-term Debt and Credit Agreement

The Company’s debt at December 31, 2024 consisted of the following:

Total term loan outstanding$—
Amounts outstanding under the Revolving Credit Facility195,000
Total outstanding indebtedness195,000
Less: amounts expected to be repaid within one year—
Total long-term debt due after one year$195,000

At December 31, 2024, the Company assessed the Revolving Credit Facility (defined below) and determined that such amounts approximated fair value. The fair values of the debt are based on quoted inactive market prices and are therefore classified as Level 2 within the valuation hierarchy.

Credit Agreement

On September 30, 2016, the Company as the borrower, entered into a Credit Agreement with Bank of America, as administrative agent (the "Original Credit Agreement"), which was amended on February 21, 2018 (the "First Amended and Restated Credit Agreement"), and further amended on February 19, 2020 (the “Second Amended and Restated Credit Agreement”). The Second Amended and Restated Credit Agreement had afive-year term with a scheduled maturity date of February 21, 2023.

On October 27, 2021, the Company completed a refinancing of the Second Amended and Restated Credit Agreement by entering into a new Credit Agreement (the “Credit Agreement”), among the Company, the lenders party thereto, the swing line lenders party thereto, the letter of credit issuers party thereto and Truist Bank, as administrative agent, which provides for a new senior secured revolving credit facility in an aggregate principal amount of $500 million (the “Revolving Credit Facility”).

Borrowings under the Revolving Credit Facility are subject to customary borrowing conditions.

The Revolving Credit Facility has a scheduled maturity date of October 27, 2026. The Credit Agreement permits the Company to utilize up to $40 million of the Revolving Credit Facility for the issuance of letters of credit and up to $40 million for swing line loans. The Company has the option to establish a new class of term loans and/or increase the amount of the Revolving Credit Facility in an aggregate principal amount for all such incremental term loans and increases of the Revolving Credit Facility of up to the sum of (x) $175 million plus (y) an amount such that the Company’s Consolidated First Lien Secured Leverage Ratio (as defined in the Credit Agreement) would not be greater than 2.75 to 1.00, in each case, to the extent that any one or more lenders, whether or not currently party to the Credit Agreement, commits to be a lender for such amount or any portion thereof.

With the cessation of LIBOR on June 30, 2023 and subject to the First Amendment to the Credit Agreement, dated as of June 27, 2023, the Eurodollar Rate was replaced with the Adjusted Term SOFR as an alternative benchmark rate for purposes of the Credit Agreement. The transition was effective July 1, 2023. Borrowings under the Credit Agreement bear interest at a rate equal to either the sum of a base rate plus a margin ranging from 0.25% to 1.25% or the sum of an Adjusted Term SOFR rate plus a margin ranging from 1.25% to 2.25%, with either such margin varying according to the Company’s Consolidated Leverage Ratio (as defined in the Credit Agreement). The Company is also required to pay a commitment fee in respect of unused commitments under the Revolving Credit Facility, if any, at a rate ranging from 0.15% to 0.35% per annum depending on the Company’s Consolidated Leverage Ratio.

Substantially all tangible and intangible assets of the Company and its domestic subsidiaries are pledged as collateral to secure the obligations under the Credit Agreement.

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, pay cash dividends, incur debt or liens, redeem or repurchase stock of the Company, enter into transactions with affiliates, make investments, make capital expenditures, merge or consolidate with others or dispose of assets. The Credit Agreement also contains financial covenants that require the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of not less than 3.00 to 1.00 and to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less (subject to the Company’s option to elect a consolidated leverage ratio increase in connection with certain acquisitions). If the Company does not comply with the covenants in the Credit Agreement, the lenders may, subject to customary cure rights, require the immediate payment of all amounts outstanding under the Revolving Credit Facility. We were in compliance with all of our covenants at December 31, 2024.

Note 10. Postretirement Benefit Obligations

Defined Contribution Benefit Plan

On January 1, 2017, the Company established a defined contribution plan which covers all eligible U.S. employees. Our plan allows eligible employees to contribute a portion of their cash compensation to the plan on a tax-deferred basis to save for their future retirement needs. The Company matches 50% or 75% of the first 8% of contributions for employees covered by a collective bargaining agreement, dependent upon the terms of the respective collective bargaining agreement and matches 75% of the first 8% of the employee’s contribution election for all other employees. The plan’s matching contributions vest after three years of service with the Company. The Company may also provide an additional discretionary retirement savings contribution which is at the sole discretion of the Company. The Company made contributions to the defined contribution plan of $6.8 million, $6.0 million and $5.9 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Defined Benefit Pension Plan

Prior to the Spin-Off certain of our employees participated in a defined benefit pension plan (the “Shared Plan”) sponsored by Honeywell which includes participants of other Honeywell subsidiaries and operations. We accounted for our participation in the Shared Plan as a multi-employer benefit plan. Accordingly, we did not record an asset or liability to recognize the funded status of the Shared Plan. The related pension expense was allocated based on annual service cost of active participants and reported within Costs of goods sold and Selling, general and administrative expenses in the Statements of Operations.

As of the date of separation from Honeywell, these employees’ entitlement to benefits in Honeywell’s plans was frozen and they will accrue no further benefits in Honeywell’s plans. Honeywell retained the liability for benefits payable to eligible employees, which are based on age, years of service and average pay upon retirement.

Upon consummation of the Spin-Off, AdvanSix employees who were participants in a Honeywell defined benefit pension plan became participants in the AdvanSix defined benefit pension plan (“AdvanSix Retirement Earnings Plan”). The AdvanSix Retirement Earnings Plan has the same benefit formula as the Honeywell defined benefit pension plan. Moreover, vesting service, benefit accrual service and compensation credited under the Honeywell defined benefit pension plan apply to the determination of pension benefits under the AdvanSix Retirement Earnings Plan. Benefits earned under the AdvanSix Retirement Earnings Plan shall be reduced by the value of benefits accrued under the Honeywell plans.

The following tables summarize the balance sheet impact, including the benefit obligations, assets and funded status associated with the AdvanSix Retirement Earnings Plan.

Change in benefit obligation:202420232022
Benefit obligation at January 1,$93,270$80,174$91,389
Service Cost4,8774,9066,860
Interest Cost4,5244,0482,436
Actuarial losses (gains)(12,285)6,636(18,665)
Benefits Paid(3,098)(2,494)(1,846)
Benefit obligation at December 31,$87,288$93,270$80,174
Change in plan assets:
Fair value of plan assets at January 1,86,08477,36271,252
Actual return on plan assets6,05311,216(12,044)
Benefits paid(3,098)(2,494)(1,846)
Company Contributions——20,000
Fair value of plan assets at December 31,89,03986,08477,362
Under (Over)-Funded status of plan$(1,751)$7,186$2,812
Amounts recognized in Balance Sheet consists of:
Accrued pension liabilities-current (1)$—$3,526$2,812
Accrued pension liabilities-noncurrent (2)—3,660—
Pension asset-noncurrent (3)(1,751)——
Total pension liabilities (assets) recognized$(1,751)$7,186$2,812

(1) Included in accrued liabilities on Balance Sheet

(2) Included in postretirement benefit obligations on Balance Sheet

(3) Included in other assets on Balance Sheet

Pension amount recognized in accumulated other comprehensive loss (income) associated with the Company's pension plan are as follows for:

Years Ended December 31,
202420232022
Transition obligation$—$—$—
Prior service cost———
Net actuarial (gain) loss(14,725)(1,271)(1,087)
Pension amounts recognized in other comprehensive loss (income)$(14,725)$(1,271)$(1,087)

The components of net periodic benefit cost and other amounts recognized inother comprehensive income for our pension plan include the following components:

Years Ended December 31,
202420232022
Net periodic pension cost (benefit)
Service cost$4,877$4,906$6,860
Interest cost4,5244,0482,436
Expected return on plan assets(4,884)(4,396)(4,463)
Recognition of actuarial losses———
Net periodic Pension Cost4,5174,5584,833
Other changes in benefits obligations recognized in other comprehensive loss (income)
Actuarial losses (gains)(13,455)(184)(2,157)
Total recognized in other comprehensive income(13,455)(184)(2,157)
Total net periodic pension cost (benefit) recognized in Other comprehensive income$(8,938)$4,374$2,676

The estimated actuarial loss (gain) that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost in 2024 and 2023 wasnil.

Significant actuarial assumptions used in determining the benefit obligations and net periodic benefit cost for our pension plan were as follows:

Key actuarial assumptions used to determine benefit obligations at December 31, · 2024 · 2023 · 2022
Effective discount rate for benefit obligation5.8%5.1%5.3%
Expected annual rate of compensation increase2.9%2.9%2.9%
Key actuarial assumptions used to determine the net periodic benefit cost for the years ended December 31,202420232022
Effective discount rate for service cost5.1%5.3%3.1%
Effective discount rate for interest cost4.9%5.1%2.7%
Expected long-term rate of return6.5%6.5%6.5%
Expected annual rate of compensation increase2.9%2.9%2.4%

The discount rate for our pension plan reflects the current rate at which the associated liabilities could be settled at the measurement date of December 31 of a given year. To determine discount rates for our pension plan, we use a modeling process that involves matching the expected cash outflows of our benefit plan to a yield curve constructed from a portfolio of high quality, fixed-income debt instruments. We use the single weighted-average yield of this hypothetical portfolio as a discount rate benchmark.

The long-term expected rate of return on funded assets is developed by using forward-looking long-term return assumptions for each asset class. Management incorporates the expected future investment returns on current and planned asset allocations using information from external investment consultants as well as management judgment. A single rate is then calculated as the weighted average of the target asset allocation percentages and the long-term return assumption for each asset class.

The accumulated benefit obligation for our pension plan was $79.7 million, $81.3 million and $69.3 million as of December 31, 2024, 2023 and 2022, respectively.

Benefit payments, including amounts to be paid from Company assets, and reflecting expected future service, as appropriate, are expected to be paid during the following years:

2025$3,942
20264,485
20274,985
20285,427
20296,072
Thereafter35,584

Our general funding policy for our pension plan is to contribute amounts at least sufficient to satisfy regulatory funding standards. The Company made pension plan contributions sufficient to satisfy pension funding requirements under the AdvanSix Retirement Earnings Plan as follows:

Years Ended December 31,
202420232022
1st Quarter$—$—$—
2nd Quarter——10,000
3rd Quarter——5,000
4th Quarter——5,000
Total$—$—$20,000

The Company expects to make pension plan contributions during 2025 sufficient to satisfy pension funding requirements of up to $1.0 million, if any, as well as evaluate contributions in future years sufficient to satisfy pension funding requirements in those periods.

The pension plan assets are invested through a master trust fund. The strategic asset allocation for the trust fund is selected by the Company's Investment Committee reflecting the results of comprehensive asset and liability modeling. The Investment Committee establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk.

The target asset allocation percent for the Company's pension plan assets is summarized as follows:

Years Ended December 31,
20242023
Cash and cash equivalents3%3%
US and non-US equity securities44%64%
Fixed income / real estate / other securities33%33%
Alternative Equity20%—%
Total Pension Assets100%100%

Fixed income and other securities include investment grade securities covering the Treasury, agency, asset-backed, mortgage-backed and credit sectors of the U.S. Bond Market, as well as listed real estate companies and real estate investment trusts located in both developed and emerging markets.

Fair Value at December 31,
Fair Value Measurements202420232022
Investments valued using NAV per share
Emerging Markets Region Equities$5,184$4,839$4,427
International Region Equities17,61816,97514,370
United States Equities41,23538,32431,235
United States Bonds22,03422,98820,115
Real Estate1,3601,3911,563
Cash Fund1,6081,5675,652
Total Pension Plan Assets at Fair Value$89,039$86,084$77,362

The pension plan assets are invested in collective investment trust funds as shown above. These investments are measured at fair value using the net asset value per share practical expedient and have not been classified in the fair value hierarchy.

Note 11. Commitments and Contingencies

Litigation

The Company is subject to a number of lawsuits, investigations and disputes, some of which involve substantial amounts claimed, arising out of the conduct of the Company or other third-parties in the normal and ordinary course of business. A liability is recognized for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on an analysis of each matter with the assistance of legal counsel and, if applicable, other experts.

Given the uncertainty inherent in such lawsuits, investigations and disputes, the Company does not believe it is possible to develop estimates of reasonably possible loss in excess of current accruals for these matters. Considering the Company’s past experience and existing accruals, the Company does not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on the Company’s Consolidated Balance Sheets, results of operations or cash flows. Potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause the Company to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on the Company’s consolidated results of operations, balance sheet and/or operating cash flows in the periods recognized or paid.

We assumed from Honeywell all health, safety and environmental (“HSE”) liabilities and compliance obligations related to the past and future operations of our current business, as well as all HSE liabilities associated with our three current manufacturing locations and the other locations used in our current operations, including any cleanup or other liabilities related to any contamination that may have occurred at such locations in the past. Honeywell retained all HSE liabilities related to former business locations or the operation of our former businesses. Although we have ongoing environmental remedial obligations at certain of our facilities, in the past three years, the associated remediation costs have not been material, and we do not expect our known remediation costs to be material for 2025.

Unconditional Purchase Obligations

In the normal course of business, the Company makes commitments to purchase goods with various vendors in the normal course of business which are consistent with our expected requirements and primarily relate to cumene, sulfur and natural gas as well as a long-term agreement for loading, unloading and the handling of a portion of our ammonium sulfate export volumes.

Future minimum payments for these unconditional purchase obligations as of December 31, 2024 are as follows (dollars in thousands):

YearAmount
2025$310,703
2026152,400
2027142,561
2028140,760
2029140,760
Thereafter99,000
$986,184

Note 12. Changes in Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) are as follows:

CurrencyTranslationAdjustmentPostretirementBenefitObligationsAdjustmentChanges inFair Value ofEffective CashFlow HedgesAccumulatedOtherComprehensiveIncome (loss)
Balance at December 31, 2021$(5,112)$(882)$(545)$(6,539)
Other comprehensive income (loss)142,1581,5763,748
Amounts reclassified from accumulated othercomprehensive income (loss)——(671)(671)
Income tax expense (benefit)—(518)(217)(735)
Current period change141,6406882,342
Balance at December 31, 2022(5,098)758143(4,197)
Other comprehensive income (loss)63184(197)50
Amounts reclassified from accumulated othercomprehensive income (loss)————
Income tax expense (benefit)—(44)473
Current period change63140(150)53
Balance at December 31, 2023(5,035)898(7)(4,144)
Other comprehensive income (loss)(109)13,454—13,345
Amounts reclassified from accumulated othercomprehensive income (loss)————
Income tax expense (benefit)—(3,231)—(3,231)
Current period change(109)10,223—10,114
Balance at December 31, 2024$(5,144)$11,121$(7)$5,970

Note 13. Earnings Per Share

The details of the earnings per share calculations for the years ended December 31, 2024, 2023 and 2022 are as follows:

Years Ended December 31,
202420232022
Basic
Net Income$44,149$54,623$171,886
Weighted average common shares outstanding26,828,33827,302,25427,969,436
EPS – Basic$1.65$2.00$6.15
Years Ended December 31,
202420232022
Diluted
Net Income$44,149$54,623$171,886
Weighted average common shares outstanding – Basic26,828,33827,302,25427,969,436
Dilutive effect of unvested equity awards426,875705,3761,061,671
Weighted average common shares outstanding – Diluted27,255,21328,007,63029,031,107
EPS – Diluted$1.62$1.95$5.92

Diluted EPS is computed based upon the weighted average number of common shares outstanding for the year plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the year.

The diluted EPS calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. For the years ended December 31, 2024, 2023 and 2022, stock options of 834,288,475,359 and 172,808, respectively, were anti-dilutive and excluded from the computations of dilutive EPS.

In September 2017, the Board of Directors (the "Board") adopted the AdvanSix Inc. Deferred Compensation Plan (the “DCP”), effective January 1, 2018. Pursuant to the DCP, our directors may elect to defer their cash retainer fees and allocate their deferrals to the AdvanSix stock unit fund. Each unit allocated under the stock unit fund represents the economic equivalent ofone share of common stock. Units are paid out in shares of AdvanSix common stock upon distribution. As of December 31, 2024, a total of 71,726 units were allocated to the AdvanSix stock unit fund under the DCP.

On May 4, 2018, the Company announced that the Board authorized a share repurchase program of up to $75 million of the Company’s common stock. On February 22, 2019, the Company announced that the Board authorized a share repurchase program of up to an additional $75 million of the Company's common stock, which was in addition to the remaining capacity available under the May 2018 share repurchase program. Repurchases may be made, from time to time, on the open market, including through the use of trading plans intended to qualify under Rule 10b5-1 of the Exchange Act of 1934, as amended (the "Exchange Act"). The size and timing of these repurchases will depend on pricing, market and economic conditions, legal and contractual requirements and other factors. The share repurchase program has no expiration date and may be modified, suspended or discontinued at any time. The par value of the shares repurchased is applied to Treasury stock and the excess of the purchase price over par value is applied to Additional paid in capital. During 2024, the Company had repurchased 403,654 shares of common stock, including 152,333 shares withheld to cover the tax withholding obligations in connection with the vesting awards, for an aggregate of $10.4 million at a weighted average market price of $25.80 per share. The purchase of shares reduces the weighted average number of shares outstanding in the basic and diluted earnings per share calculations.

Note 14. Stock-Based Compensation Plans

On September 8, 2016, prior to the Spin-Off, our Board adopted, and Honeywell, as our sole stockholder, approved, the 2016 Stock Incentive Plan of AdvanSix Inc. and its Affiliates, and the material terms of performance-based compensation were approved by the Company's stockholders for tax purposes at our 2017 annual meeting of stockholders (the "Original Plan"). The Original Plan was amended and restated as the 2016 Stock Incentive Plan of AdvanSix Inc. and its Affiliates, as Amended and Restated, which was approved by stockholders of the Company at the Annual Meetings of Stockholders held on June 23, 2020 and subsequently on June 15, 2022 (the “Equity Plan”). As a result, no further grants will be made under the Original Plan. The Equity Plan provides for the grant of stock options, stock appreciation rights, performance awards, restricted stock units, restricted stock, other stock-based awards and non-share-based awards. The maximum aggregate number of shares of our common stock that may be issued under all stock-based awards granted under the Equity Plan is 2,615,100, subject to adjustment in accordance with the terms of the Equity Plan. Under the Equity Plan, the shares underlying all full-value awards, including those granted to non-employee directors, will be counted against the share reserve on a 1.55-for-one basis. Shares underlying stock option awards and SARs will be counted against the share reserve on aone-for-one basis.

Under the terms of the Equity Plan, there were approximately 1,700,000 shares of AdvanSix common stock available for future grants of full-value awards at December 31, 2024.

Restricted Stock Units – The Company may grant RSUs to key management employees and directors that generally vest over periods ranging from 1 to 3 years. In the event cash dividends are paid to shareholders of common stock, dividend equivalents accrue on all unvested RSUs. Dividend equivalents are subject to the same termination and vesting terms as the underlying RSU. Upon vesting, the RSUs and related dividend equivalents entitle the holder to receiveone share of AdvanSix common stock for each RSU and dividend equivalent at time of vesting and are payable in AdvanSix common stock upon vesting. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The following table summarizes information about RSU activity related to the Equity Plan:

Number of RestrictedStock Units(In Thousands)Weighted Average Grant Date Fair Value (Per Share)
Non-vested at December 31, 2021442$22.11
Granted12939.44
Vested(110)30.00
Forfeited(65)22.25
Non-vested at December 31, 202239625.53
Granted17834.75
Vested(218)15.83
Forfeited(19)38.92
Non-vested at December 31, 202333735.97
Granted32025.77
Vested(150)28.52
Forfeited(47)33.53
Non-vested at December 31, 2024460$31.53

As of December 31, 2024, there was approximately $6.8 million of total unrecognized compensation cost related to non-vested RSUs granted under the Equity Plan which is expected to be recognized over a weighted-average period of 1.3 years.

The following table summarizes information about the income statement impact from RSUs for the Years Ended December 31, 2024, 2023 and 2022:

Years Ended December 31,
202420232022
Compensation expense$5,670$4,049$3,471
Future income tax benefit recognized$1,186$1,107$927

Stock Options –The exercise price, term and other conditions applicable to each option granted under the Equity Plan are generally determined by the Compensation Committee of the Board. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of our stock on that date. The fair value is recognized as an expense over the employee’s requisite service period (generally the vesting period of the award). Options generally vest over periods ranging from 1 to 3 years.

The following table summarizes information about the income statement impact from stock options for the years ended December 31, 2024, 2023 and 2022.

Years Ended December 31,
202420232022
Compensation expense$822$1,651$1,467
Future income tax benefit recognized$1,498$1,215$1,033

The fair value related to stock options granted was determined using Black-Scholes option pricing model and the weighted average assumptions are shown in the table below:

Years Ended December 31,
Key Black-Scholes Assumptions202420232022
Risk-free interest rate—4.1%1.8%
Expected term (years)—66
Volatility—46.5%40.2%
Dividend yield—1.4%1.3%
Fair value per stock option—$18.04$14.01

The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Volatility is determined based on the average volatility of peer companies with similar option terms. The expected term is determined using a simplified approach, calculated as the mid-point between the vesting period and the contractual term of the award. The risk-free interest rate is determined based upon the yield of an outstanding U.S. Treasury note with a term equal to the expected term of the option granted. No stock options were awarded during 2024.

The following table summarizes information about stock option activity related to the Equity Plan:

Number of Shares(In Thousands)Weighted Average Exercise Price (Per Share)Weighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value
Outstanding at December 31, 202190626.137.42$19,123
Exercisable at December 31, 2021443$29.426.54$7,895
Granted12339.13
Exercised(69)24.23
Forfeited(21)27.81
Expired(56)30.94
Outstanding at December 31, 202288327.976.81$8,870
Exercisable at December 31, 2022578$27.496.06$6,082
Granted8641.15
Exercised(9)28.14
Forfeited——
Expired(3)33.27
Outstanding at December 31, 202395729.266.17$4,446
Exercisable at December 31, 2023728$26.475.46$4,412
Granted——
Exercised(24)17.96
Forfeited(8)40.43
Expired(8)36.12
Outstanding at December 31, 202491729.405.16$3,536
Exercisable at December 31, 2024828$28.204.87$3,536

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the year and the exercise price, multiplied by the number of in-the-money options) that would have been received had all option holders exercised their in-the-money options at year-end. The amount changes based on the fair market value of the Company’s stock.

As of December 31, 2024, there was $0.3 million of unrecognized stock-based compensation expense related to stock options that is expected to be recognized over a weighted average period of approximately 0.5 years.

Performance Stock Units – The Company may issue PSUs to key senior management employees which, upon vesting, convertone-for-one to AdvanSix common stock. In the event cash dividends are paid to shareholders of common stock, dividend equivalents will accrue on all unvested PSUs. Dividend equivalents are subject to the same termination, vesting and performance terms as the underlying PSU award. The actual number of shares an employee receives for each PSU and related dividend equivalent depends on the Company’s performance against certain metrics, including cumulative Earnings Per Share and average annual Return on Investment goals over three-year performance and vesting periods. Commencing with the 2021 awards, a market-based factor has the potential to increase or decrease the performance award by 10%. This metric is calculated based upon how the Company's Total Shareholder Return compared to that of its peer group over the vesting period. Each grantee is granted a target level of PSUs and may earn between 0% and 200% of the target level depending on the Company’s performance against the financial goals.

The following table summarizes information about PSU activity related to the Equity Plan:

Number of PerformanceStock Units(In Thousands)Weighted Average Grant Date Fair Value (Per Share)
Non-vested at December 31, 2021404$20.04
Granted10141.63
Vested(78)30.69
Forfeited(32)22.30
Non-vested at December 31, 202239523.04
Granted9342.63
Vested(193)14.29
Forfeited(1)38.84
Non-vested at December 31, 202329437.77
Granted14428.00
Vested(108)30.37
Forfeited(33)35.86
Non-vested at December 31, 2024297$35.95

The fair value of the PSUs is principally based on the fair market value of the Company’s stock at the grant date. The number of underlying shares to be issued will be based on actual performance achievement over the performance period. The accrual of compensation costs is based on our estimate of the probable expected value of the award. The fair value of each PSU grant is amortized monthly into compensation expense on a straight-line basis over a vesting period of 36 months. Changes in expected probable value are recorded as compensation expense on a catch-up basis in the month in which the change is identified. Any remaining balance is amortized monthly into compensation expense on a straight-line basis over the remaining vesting period. The Company assumes that forfeitures will be minimal, and estimates forfeitures at time of issuance, which results in a reduction in compensation expense. As the payout of PSUs includes dividend equivalents, no separate dividend yield assumption is required in calculating the fair value of the PSUs. The Company initiated a dividend during the fourth quarter of 2021.

As of December 31, 2024, there was approximately $3.3 million of total unrecognized compensation cost related to non-vested PSUs granted under the Equity Plan which is expected to be recognized over a weighted-average period of 1.3 years.

The following table summarizes information about the income statement impact from PSUs for the year ended December 31, 2024, 2023 and 2022.

Years Ended December 31,
202420232022
Compensation expense$1,411$2,612$5,343
Future income tax benefit recognized$216$703$840

Note 15. Goodwill and Intangible Assets

Intangible assets with finite lives acquired through a business combination are recorded at fair value, less accumulated amortization. Customer relationships and trade-names are amortized on a straight-line basis over their expected useful lives of 15 to 20 years and 5 years, respectively.

Goodwill

There was no change in the carrying amount of goodwill for the year ended December 31, 2024.

Finite-Lived Intangible Assets

Intangible assets subject to amortization were as follows:

December 31, 2024December 31, 2023
Gross Carrying AmountAccumulated AmortizationNet Book ValueGross Carrying AmountAccumulated AmortizationNet Book Value
Customer relationships$36,820$(5,666)$31,154$36,820$(3,760)$33,060
Licenses18,451(6,919)11,53218,451(5,996)12,455
Trade names1,100(642)4581,100(422)678
Total$56,371$(13,227)$43,144$56,371$(10,178)$46,193

For the years ended December 31, 2024 and 2023, the Company recorded amortization expense on intangible assets of $3.0 million and $3.0 million, respectively.

The estimated aggregate amortization expense for each of the next five years is as follows:

YearAmount
2025$3,049
20263,049
20272,866
20282,829
20292,829

Note 16. Acquisitions

In February 2022, the Company acquired the stock of U.S. Amines, a leading North American producer of alkyl and specialty amines serving high-value end markets such as agrochemicals and pharmaceuticals for a purchase price of approximately $97.5 million, net of cash acquired.

In accordance with ASC 805, this transaction was accounted for as a business combination. The transaction resulted in the Company acquiring tangible assets and finite-lived intangible assets, comprised of customer relationships (approximately $33 million) and trademarks (approximately $1 million) which reflect the value of the benefit derived from incremental revenue and related cash flows as a direct result of the customer relationships and name brand. These intangible assets are being amortized on a straight-line basis over their estimated useful lives of 20 years and 5 years, respectively. The residual amount of the purchase price in excess of the value of the tangible and definite-lived intangible assets was allocated to goodwill.

Note 17. Supplier Finance Programs

The Company has entered into a supply chain finance program with a financial intermediary providing participating suppliers the option to be paid by the intermediary earlier than the original invoice due date. AdvanSix’s responsibility is limited to making payments to the intermediary based upon payment terms negotiated with the suppliers, regardless of whether the intermediary pays the supplier in advance of the original due date. The Company’s payment terms with suppliers are consistent, regardless of whether a vendor participates in the supply chain finance program or not. All related agreements are terminable by either party upon at least 30 days’ notice.

The total amount due to the financial intermediaries to settle supplier invoices under all of its supplier finance programs at December 31, 2024 and 2023, are as follows (in thousands):

December 31,
20242023
Confirmed obligations outstanding at the beginning of the year$17,076$17,434
Invoices confirmed during the year62,93363,136
Confirmed invoices paid during the year(60,854)(63,494)
Confirmed obligations outstanding at the end of the year$19,155$17,076

These amounts outstanding are included in Accounts payable.

Note 18. Segment Related Information

The Company has concluded that it is a single operating segment and a single reportable segment: chemical manufacturing. Its larger manufacturing sites are vertically integrated and leverage cross-plant resources, including centralized supply chain and procurement functions. This production process uses one key raw material, cumene, as the input to products produced for sale through the sales channels and end markets the Company serves. Production rates and output volumes are managed across locations to align with the Company’s overall operating plan. Additionally, the Company’s operating results, which are evaluated regularly to make decisions about resource allocation and performance assessment by the CODM, our CEO and President, are on a consolidated basis.

The chemical manufacturing segment derives its revenues by innovating and delivering essential products in the industries of nylon solutions, plant nutrients, and chemical intermediates to its customers in a wide variety of end markets and applications, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics.

The CODM’s performance assessment and resource allocation for the chemical manufacturing segment is based on net income which is also reported on the income statement as net income, the measure of segment assets which is also reported on the balance sheet as total assets, and capital expenditures which is also reported in management’s discussion and analysis.

The CODM uses net income generated from segment assets in deciding whether to reinvest profits into the segment or into other parts of the entity, such as for acquisitions or to pay dividends. The CODM also uses net income to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment and in establishing management’s compensation. Lastly, the CODM uses capital expenditures estimate the cash-generating potential and cash requirements of the segment.

Significant expense information reviewed by the CODM was as follows (in thousands):

Years Ended December 31,
202420232022
Revenue$1,517,557$1,533,599$1,945,640
Less:
Variable cost of goods sold *691,300711,169973,605
Plant costs487,671470,457470,696
Freight and distribution costs176,849177,095174,407
Selling, general, and administrative expense94,02395,53887,748
Other segment items **23,56524,71767,298
Segment net income$44,149$54,623$171,886

*Variable costs of goods sold includes raw materials and various utility expenses

**Other segment items include research and development expense, interest income and expense, capitalized interest, other non-operating expense, and income tax expense.

Note 19. Other Non-operating (Income) Expense, Net

For the year ended December 31, 2024, Other non-operating (income) expense, net primarily includes a pre-tax loss of approximately $1.2 million related to a reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the Company's exit from the Oben Holding Group S.A. alliance in the prior year.

Note 20. Subsequent Events

As announced on February 21, 2025, the Board declared a quarterly cash dividend of $0.16 per share on the Company's common stock, payable on March 24, 2025 to stockholders of record as of the close of business on March 10, 2025.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.